Onconic Therapeutics Inc. (KOSDAQ:476060)

South Korea flag South Korea · Delayed Price · Currency is KRW
20,550
+1,570 (8.27%)
May 21, 2026, 1:40 PM KST
Market Cap851.97B +198.8%
Revenue (ttm)53.39B +259.8%
Net Income15.78B
EPS347.92
Shares Out44.89M
PE Ratio54.55
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume267,948
Average Volume540,221
Open19,270
Previous Close18,980
Day's Range19,270 - 20,700
52-Week Range5,000 - 28,900
Betan/a
RSI39.55
Earnings DateMar 20, 2026

About Onconic Therapeutics

Onconic Therapeutics, Inc. is a biopharmaceutical company. It engages in the research and development of new drugs in the field of acid-related diseases and anti cancer. The company was founded on May 7, 2020 and is headquartered in Seoul, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2020
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 476060
Full Company Profile

Financial Performance

Financial Statements